Clinical trials have demonstrated that starting with a lower dose (0.25 mg weekly) and gradually increasing helps minimise the severity and onset of side effects, which is why the standard UK prescribing protocol follows a careful dose-escalation schedule
Tirzepatide goes a step further by also activating GIP receptors , offering a dual action thats proving to be highly effective in clinical trials
What matters more is having realistic expectations, understanding the side effects, and committing to the lifestyle changes that make these medications most effective
The peptide influences endothelial function, inflammatory responses, and tissue remodeling processes
At the bottom of this blog post is a chart identifying and linking to the patents that Novo Nordisk has listed in the Orange Book for its three semaglutide medications, Ozempic, Wegovy and Rybelsus